Goldman Sachs Group, Inc. (The) set a €73.00 ($85.88) price objective on Gerresheimer AG (ETR:GXI) in a research report released on Friday, July 14th. The brokerage currently has a neutral rating on the stock.
Several other equities research analysts have also recently weighed in on the company. Berenberg Bank set a €83.00 ($97.65) price objective on Gerresheimer AG and gave the company a buy rating in a research note on Thursday, July 13th. J P Morgan Chase & Co set a €99.80 ($117.41) target price on Gerresheimer AG and gave the company a buy rating in a report on Wednesday, May 31st. Deutsche Bank AG set a €82.00 ($96.47) target price on Gerresheimer AG and gave the company a buy rating in a report on Friday, July 7th. Kepler Capital Markets set a €70.00 ($82.35) target price on Gerresheimer AG and gave the company a sell rating in a report on Thursday, July 13th. Finally, Commerzbank Ag set a €73.00 ($85.88) target price on Gerresheimer AG and gave the company a neutral rating in a report on Thursday, July 13th. One analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company. Gerresheimer AG currently has a consensus rating of Hold and a consensus target price of €79.80 ($93.88).
Gerresheimer AG (ETR:GXI) traded down 0.354% during mid-day trading on Friday, reaching €68.314. 77 shares of the company’s stock traded hands. Gerresheimer AG has a 12-month low of €64.00 and a 12-month high of €79.47. The stock has a 50 day moving average of €70.08 and a 200 day moving average of €72.89. The company has a market cap of €2.14 billion and a P/E ratio of 18.924.
ILLEGAL ACTIVITY WARNING: This news story was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2017/08/12/gerresheimer-ag-gxi-pt-set-at-73-00-by-goldman-sachs-group-inc-the-updated-updated-updated.html.
About Gerresheimer AG
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
What are top analysts saying about Gerresheimer AG? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Gerresheimer AG and related companies.